quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:45·148d
INSIDERFiling
Bowhead Specialty Holdings Inc. logo

CEO and President Sills Stephen Jay gifted 75,000 shares and received a gift of 75,000 shares, decreasing direct ownership by 9% to 786,000 units (SEC Form 4)

BOW· Bowhead Specialty Holdings Inc.
Finance
Original source

Companies

  • BOW
    Bowhead Specialty Holdings Inc.
    Finance

Recent analyst ratings

  • Nov 25UpdateRBC Capital Mkts$33.00
  • Apr 16UpdatePiper Sandler$44.00
  • Mar 3UpdateKeefe Bruyette$44.00
  • Jun 17UpdateRBC Capital Mkts$32.00
  • Jun 17UpdateJP Morgan$27.00
  • Jun 17UpdateJMP Securities$31.00

Related

  • PR24d
    Bowhead Specialty to Announce First Quarter 2026 Earnings on May 5, 2026; Also Announces Upcoming Investor Events
  • SEC38d
    SEC Form DEF 14A filed by Bowhead Specialty Holdings Inc.
  • INSIDER41d
    CEO and President Sills Stephen Jay received a gift of 127,700 shares and gifted 127,700 shares, decreasing direct ownership by 13% to 832,150 units (SEC Form 4)
  • SEC58d
    SEC Form 10-K filed by Bowhead Specialty Holdings Inc.
  • SEC58d
    Bowhead Specialty Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR58d
    Bowhead Specialty Holdings Inc. Reports Fourth Quarter and Full Year 2025 Results
  • INSIDER59d
    CFO and Treasurer Mulcahey Brad was granted 25,145 shares and covered exercise/tax liability with 1,274 shares, increasing direct ownership by 21% to 136,327 units (SEC Form 4)
  • INSIDER59d
    Chief Underwriting Officer Newman David John was granted 23,488 shares and covered exercise/tax liability with 1,443 shares, increasing direct ownership by 8% to 297,195 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022